Literature DB >> 16728428

Nephrotoxicity of ciclosporin A: short-term gain, long-term pain?

Jeremy R Chapman, Brian J Nankivell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16728428     DOI： 10.1093/ndt/gfl219

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  12 in total

1.  Nonapoptotic death of Saccharomyces cerevisiae cells that is stimulated by Hsp90 and inhibited by calcineurin and Cmk2 in response to endoplasmic reticulum stresses.

Authors:  Drew D Dudgeon; Nannan Zhang; Olufisayo O Ositelu; Hyemin Kim; Kyle W Cunningham
Journal:  Eukaryot Cell       Date:  2008-09-19

Review 2.  Effectiveness and safety of calcineurin inhibitor withdrawal in kidney transplantation: a meta-analysis of randomized controlled trials.

Authors:  Hongwei Bai; Yeyong Qian; Bingyi Shi; Zhen Wang; Gang Li; Yu Fan; Ming Yuan; Lupeng Liu
Journal:  Clin Exp Nephrol       Date:  2015-03-29       Impact factor: 2.801

3.  ER-mitochondrial calcium flow underlies vulnerability of mechanosensory hair cells to damage.

Authors:  Robert Esterberg; Dale W Hailey; Edwin W Rubel; David W Raible
Journal:  J Neurosci       Date:  2014-07-16       Impact factor: 6.167

4.  Polylactide-cyclosporin A nanoparticles for targeted immunosuppression.

Authors:  Jamil Azzi; Li Tang; Robert Moore; Rong Tong; Najib El Haddad; Takurin Akiyoshi; Bechara Mfarrej; Sunmi Yang; Mollie Jurewicz; Takaharu Ichimura; Neal Lindeman; Jianjun Cheng; Reza Abdi
Journal:  FASEB J       Date:  2010-06-14       Impact factor: 5.191

5.  Au-ACRAMTU-PEt3 Alters Redox Balance To Inhibit T Cell Proliferation and Function.

Authors:  P Kent Langston; Mu Yang; Ulrich Bierbach; Derek Parsonage; Leslie B Poole; Madeline J Price; Jason M Grayson
Journal:  J Immunol       Date:  2015-07-24       Impact factor: 5.422

6.  Long-Term Impact of Cyclosporin Reduction with MMF Treatment in Chronic Allograft Dysfunction: REFERENECE Study 3-Year Follow Up.

Authors:  L Frimat; E Cassuto-Viguier; F Provôt; L Rostaing; B Charpentier; K Akposso; M C Moal; P Lang; D Glotz; S Caillard; D Ducloux; C Pouteil-Noble; S Girardot-Seguin; M Kessler
Journal:  J Transplant       Date:  2010-07-28

Review 7.  Pharmacogenetics and drug-induced nephrotoxicity in renal transplant recipients.

Authors:  Sepideh Zununi Vahed; Mohammadreza Ardalan; Nasser Samadi; Yadollah Omidi
Journal:  Bioimpacts       Date:  2015-02-21

8.  Sirolimus conversion efficacy for graft function improvement and histopathology in renal recipients with mild to moderate renal insufficiency.

Authors:  Dong Jin Joo; Chul Woo Yang; Hyeon Joo Jeong; Beom Jin Lim; Kyu Ha Huh; Byung Ha Chung; Yeong Jin Choi; Shin-Wook Kang; Yu Seun Kim
Journal:  J Korean Med Sci       Date:  2014-07-30       Impact factor: 2.153

9.  Subclinical toxicity of calcineurin inhibitors in repeated protocol biopsies: an independent risk factor for chronic kidney allograft damage.

Authors:  Karel Krejcí; Tomás Tichý; Miroslav Hrubý; Pavel Horák; Hana Ciferská; Vladko Horcicka; Pavel Strebl; Sadek Al-Jabry; Petr Bachleda; Josef Zadrazil
Journal:  Transpl Int       Date:  2009-11-09       Impact factor: 3.782

10.  Targeted Delivery of Immunomodulators to Lymph Nodes.

Authors:  Jamil Azzi; Qian Yin; Mayuko Uehara; Shunsuke Ohori; Li Tang; Kaimin Cai; Takaharu Ichimura; Martina McGrath; Omar Maarouf; Eirini Kefaloyianni; Scott Loughhead; Jarolim Petr; Qidi Sun; Mincheol Kwon; Stefan Tullius; Ulrich H von Andrian; Jianjun Cheng; Reza Abdi
Journal:  Cell Rep       Date:  2016-04-28       Impact factor: 9.423
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.